Amicus Therapeutics, Inc. (NASDAQ:FOLD)

Drjohn08318 (< 20) Submitted: 1/12/2012 2:55:25 PM : Start Price: $4.14 FOLD Score: +57.87

Awesome company making great product; employees are happy, and I predict great things from them in the near future....

MATTALANKANE (54.80) Submitted: 7/13/2010 12:14:16 AM : Start Price: $2.07 FOLD Score: +200.57

IF THE COMPANY CAN BRANCH OUT THEIR PIPELINE AND OVERLAP WITH DUAL ALZHEIMERS USES FOR THEIR DRUGS................THAN WATCH OUT!!!!!!

portefeuille (99.81) Submitted: 6/30/2010 10:34:41 AM : Start Price: $2.15 FOLD Score: +183.08

see this post.
http://caps.fool.com/Blogs/biopharmaceuticals-fold/413534.

mansloth (97.01) Submitted: 1/8/2009 8:32:13 PM : Start Price: $7.92 FOLD Score: -65.40

Therapeutics for protein folding diseases are going to be trendy over the next couple of years. More (and perhaps better) competitors with a focus on protein folding diseases will go public over the course of the next five years, while established ones like this will get gobbled up.

WordTickers (86.96) Submitted: 5/31/2008 12:19:40 PM : Start Price: $9.91 FOLD Score: -35.70

Testing out a portfolio with outperforms on stocks with tickers that spell words.

lw100 (< 20) Submitted: 5/14/2008 11:57:18 AM : Start Price: $10.28 FOLD Score: -33.18

Impressive pipeline. Great results

SanDieguito (< 20) Submitted: 12/20/2007 10:17:40 AM : Start Price: $9.99 FOLD Score: +29.51

down $5 to $10